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Abstract
Carboxymethyl-glucan (CM-G) is a soluble derivative from Saccharomyces cerevisiae (1  3)(1  6)--D-glucan.
The protective efficiency of CM-G against DNA damage in cells from patients with advanced prostate cancer (PCa),
and undergoing Androgen Deprivation Therapy (ADT), was evaluated. DNA damage scores were obtained by the
comet assay, both before and after treatment with CM-G. The reduction in DNA damage, ranging from 18% to 87%,
with an average of 59%, was not related to the increased number of leukocytes in peripheral blood. The results dem-
onstrate for the first time the protective effect of CM-G against DNA damage in patients with advanced PCa. Among
smokers, three presented the highest reduction in DNA damage after treatment with CM-G. There was no observ-
able relationship between DNA damage scores before and after treatment, and age, alcoholism and radiotherapy.
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-D-glucan from the cell wall of Saccharomyces
cerevisiae is a polymer composed of repeating glucose
units, and organized into a central skeleton linked by 
(1  3) glycosidic bonds, with side chains of variable sizes
joined by  (1  6) linkages (Di Luzio et al., 1979). As the
benefits arising from the biological activity of (1 
3)(1  6)--D-glucan are limited by its insolubility in wa-
ter, studies are under way with derivatives of this polymer
inanattempttoimproveitsavailability.Solublederivatives
have additional advantages when administered in vivo,
such as the absence of toxicity and adverse effects (Miada-
ková et al., 2005). Moreover, derivatization may even en-
hance certain biological properties, such as antioxidant and
immunomodulationactivities(ChenandSeviour,2007;Xu
et al., 2009). Another important factor is the maintenance
of bioactivity, since (1  3)(1  6)--D-glucan soluble
derivativescancrossthegastrointestinalwallwithoutcaus-
ing damage to the digestive system, even when orally ad-
ministered(Chorvatovicováetal.,1996;Riceetal.,2005).
Carboxymethyl-glucan (CM-G), one of the most
studied among the soluble derivatives of S. cerevisiae
(13)(16)--D-glucan,hasbeenshowntopossesssig-
nificant bioprotective properties, such as antimutagenic,
antigenotoxic, antioxidant, and anticancer activities (Chor-
vatovicová et al., 1996; Babincová et al., 2002; Slamenová
et al., 2003; Miadaková et al., 2005). The main mechanism
proposed for these protective effects of CM-G is the capa-
bility of scavenging reactive oxygen species (Kogan et al.,
2005), even at concentrations as low as 30 M (Babincová
et al., 2002).
Prostate cancer (PCa) is the sixth most common can-
cerintheworld,andrepresentsabout10%ofallcancersdi-
agnosed. In Brazil, it is estimated that 49.530 new cases
were diagnosed in 2009. Excluding non-melanoma skin
cancer, it is the most frequent type of cancer in males and is
prevalent countrywide, and counts with the second highest
mortalityrateinBrazil(NationalCancerInstituteofBrazil,
2010).
While a man with localized PCa is more likely to die
fromothercomorbidities,theprobabilityofdeathfromPCa
exceeds other causes when clinical metastases occur. At
this stage, the aims of medical treatment are to increase the
period of short-term survival of patients and, above all, to
improve the quality of life, which often declines with pro-
gression of the disease. The standard treatment for ad-
vanced PCa is Androgen Deprivation Therapy (ADT),
during which the administration of hormone analogues of a
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Short Communicationgonadotropin-releasing hormone (GnRH) leads to receptor
desensitization, thus inhibiting the release of LH and FSH,
andresultinginchemicalcastration(HellerstedtandPienta,
2002).
The complications arising from chronic treatment, in
addition to advanced age and fixed lifestyle habits, make
patients with advanced PCa even more vulnerable. There-
fore, the use of innocuous, naturally bioactive compounds,
capableofimprovingthequalityoflifeofthesepatientscan
be a befitting alternative. Simulations of reactions that oc-
cur in the human body due to the administration of CM-G
have been reported in several experimental models, al-
though evaluation in humans is scarce. Our goal in this
study was to evaluate the possible protective effects of
CM-G against DNA damage in peripheral lymphocytes of
patientswithadvancedPCa.Thenonrandomlyselectedtar-
get population expressed a clinical cancer scenario aggra-
vated by age and lifestyle habits.
This study was undertaken after receiving approval
from the Ethics Committee for Research Involving Hu-
mans, under registration number NTC406800007 in the re-
cords of the Brazilian Information on Ethics in Research
Involving Humans (SISNEP). Patients at the Londrina
Cancer Institute (ICL), with a histological diagnosis of
stage T3 (n = 7) and T4 (n = 13) prostate adenocarcinoma
according to TNM staging (AJCC/UIAC, 2010), and un-
dergoing androgen deprivation therapy (ADT) with gose-
relin acetate, were included in this study, after signing a
written informed-consent. Individual information was col-
lected by a face-to-face questionnaire (Carrano and Nata-
rajana, 1988). The patients were kept under observation in
order to check for possible side effects from CM-G admin-
istration.
CM-G with substituition degree (DS) 0.8 was ob-
tained from S. cerevisiae insoluble -glucan (Magnani et
al. 2009). 20 mg of CM-G, with starch as the excipient ve-
hicle, were inserted into gelatin capsules. This procedure
was carried out by Vico Farma® (National Health Surveil-
lanceAgencyinBrazilnumber136420-0).Bottlescontain-
ing between 28 and 35 capsules were labeled with
instructionsforuse.Thevariablenumberofcapsuleswasto
aid in controlling consumption by patients, return of the
bottlebeingrequestedaftertheendoftreatment.Afterdaily
administration of one capsule of CM-G (Demir et al.,
2007),duringaperiodof28days,thereturnedbottleshould
contain between zero and seven capsules, depending on the
initial amount received by each patient.
Peripheral venous blood samples were collected, in a
state of fasting, on the 1
st day of treatment before ingestion
of the first capsule of CM-G, and once again after 28 days
of daily administration. The patients were arranged into
couples,withnomorethantwopatientshavingthesame1
st
or last day of ingestion. Vaccutainer tubes of 4.5 mL con-
tainingEDTAwereusedforcollectingsamples.Leukocyte
countswereobtainedbyanautomatedmethod(AbbottCell
Dyn 3200). Samples for comet assay were kept under re-
frigeration and protected from light during transport from
the ICL to the Laboratory of Mutagenesis and Oncoge-
netics at the University of Londrina, Parana State, Brazil.
Comet assays according Singh et al. (1988), with slight
modifications, were conducted immediately after arrival of
the samples in the laboratory. For the preparation of fresh-
blood slides, 20 L of peripheral blood was mixed with
180 L of 0.5% low melting temperature agarose, and ap-
plied to microscope slides pre-coated with 1.5% normal
melting temperature agarose. The slides were coverslipped
and refrigerated for 5 min at 4 °C. Duplicate coded slides
were prepared for each sample, and the samples were pro-
cessed in a randomized manner. Cells attached to the aga-
rose matrix underwent lysis by immersion in an ice-cold
solution containing 1% Triton X-100, 10% DMSO, 2.5 M
NaCl, 100 mM EDTA, and 10 mM Tris (pH 10.0), for at
least 1 h. The DNA was subsequently denatured for 20 min
in an alkaline buffer (300 mM NaOH and 1 mM EDTA, fi-
nal pH > 13) and electrophoresed for 20 min at 25 V and
300 mA (1.25 V/cm) in the same buffer. Subsequently, the
slides were neutralized (400 mM Tris, pH 7.5) and fixed
with 100% ethanol for 10 min. For visual analysis, the
slides were coded and stained with ethidium bromide
(20mg/mL),whereupononehundredcellsperpatientwere
immediately scored at 400× magnification using a fluores-
cence microscope (Nikon-Brazil) with a blue (488 nm) ex-
citation filter and yellow (515 nm) emission (barrier) filter.
Asinglepersonpersonwasassignedtoanalyzingtheslides
throughout the study by visual scoring. The cells were clas-
sified into four categories, each representing different de-
grees of DNA damage, these ranging from no visible
migration (class 0, undamaged cells) to maximum length
comet (class 3, maximally damaged cells (DC) (Kobayashi
et al., 1995; Forchhammer et al., 2008). DC frequency was
obtained by first determining the number of undamaged
(class 0) and DCs from each of classes 1, 2 and 3, and then
dividing this by the total number of cells analyzed in each
treatment. The total score for 100 nucleoids was obtained
bymultiplyingthenumberofcellsineachclassbythedam-
age class (Manoharan and Banerjee, 1985): Total score =
(0  n0)+( 1 n1)+( 2 n2)+( 3 n3), where n = number of
cells in each class analyzed. Thus, the total score could
range from 0 (100 cells presenting no damage) to 300 (all
cells presenting class 3 damage). The damage reduction
rates for each patient were determined based on scores ob-
served before and after CM-G.
The results were analyzed with MEDCAL 9.2 soft-
ware using the non-parametric Mann-Whitney test for
DNA damage scores before and after CM-G treatment, and
theWilcoxontestforleukocytecounts,consideringsignifi-
cance at p  0.05.
After completing treatment with CM-G, the number
of returned capsules patients corresponded to the use of 28
capsules in the period. Subsequently, and through weekly
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use of CM-G were reported. This included typical symp-
toms of PCa under chronic treatment for testosterone inhi-
bition, such as urinary symptoms and sexual dysfunction.
The bone pain was reported by 90% of the patients. These
effects of ADT occur due the loss in bone mineral density
(BMD),worsenedbyadvancedage(Diamondetal.,2004).
As to diet, all men mentioned the eating of red meat
and salad on an average of five and three times a week, re-
spectively.Furthermore,65%ofthepatientsreportedunin-
tentional weight-loss. When questioned, they responded
that the reduction in food intake was attributed to symp-
toms such as change in taste, dryness of the mouth, vomit-
ing, constipation and nausea. Except for two patients, who
reported a decrease in nausea, these symptoms persisted
during the treatment with CM-G.
Data for each patient, obtained from medical records
and the individual questionnaire (Table 1), show the vari-
ous individual lifestyle characteristics, such as smoking,
age, alcoholism, and exposure to chemicals and radiation,
that exerted an influence on the baseline of DNA damage.
The analysis of data on DNA damage scores, ob-
tained both before and after treatment with CM-G, showed
significant differences (p  0.05), with DNA damage re-
duction rates ranging from 18% to 87%, with an average of
59%(Figure1).ThenumberofDCsinclasses1,2and3de-
creased significantly (p  0.05) after CM-G treatment. On
the other hand, there was an increase in the number of un-
damaged cells for all patients (Figure 2). Based on reports
of increased stimulation of hematopoiesis by CM-G (Pos-
pisil et al., 1991), the reduction in DNA damage could be
attributed to an increase in the number of cells. In this way,
the average numbers of white blood cells counted before
(1,789.25  766.1 per mm
3) and after (1,827.9  757.8 per
mm
3) CM-G administration were not statistically different
(p = 0.63).
Five patients (25%) were classified as current smok-
ers. Nicotine, the most toxic component of cigarettes, is
known to cause oxidative stress by inducing the generation
of reactive oxygen species (ROS) (Sener et al., 2007). It is
known that CM-G is a potent antioxidant, which, besides
being effective even at very low concentrations, plays an
important role in protecting biological membranes against
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Table1-Dataobtainedfrommedicalreportsof20patientsoftheCancerInstituteofLondrina,ParanaState,andfromquestionnairescompletedafterfor-
mal written consent and prior to administration of carboxymethyl-glucan (CM-G).
Patient Age (years) Ethnicity TNM Goserelin
use (months)
Life style Agrochemicals
c Radiotherapy
Smoking
a Alcoholic
b
1 73 African descendent IV 6 no yes yes* no
2 77 European descendent III 6 no no yes no
3 84 European descendent IV 7 no no yes yes
4 70 Asian descendent IV 7 no no yes yes
5 63 European descendent IV 12 yes yes yes no
6 71 European descendent IV 6 no no yes no
7 71 African descendent III 8 no no yes* no
8 63 African descendent III 10 no yes yes yes
9 71 European descendent IV 19 no no yes no
10 57 European descendent IV 23 yes yes yes no
11 63 European descendent IV 6 no no no no
12 79 Asian descendent IV 36 no no yes no
13 67 African descendent IV 10 no yes yes no
14 70 African descendent III 6 yes no yes yes
15 68 European descendent III 18 no yes yes no
16 63 African descendent IV 6 no no no no
17 62 Asian descendent III 5 no yes yes no
18 52 European descendent IV 5 no no yes yes
19 76 African descendent IV 6 yes no yes yes
20 80 African descendent III 6 yes yes no no
aPatients who had quit smoking for less than one year are considered smokers.
bPatients with behavior in alcohol-dependence.
cYes = patients who have had contact or exposure to agrochemicals for  10 years.
*Patients who reported intoxication by agrochemicals.adverse effects of free radicals (Babincová et al., 2002).
Sener et al. (2007) suggested that the oral administration of
soluble -D-glucan from S. cerevisiae is effective against
chronic nicotine intoxication, thereby reducing oxidative
damage. Our data is consistent with these findings, since
among the patients appraised, three smokers (5, 19 and 20)
showedthethreehighestratesofreductioninDNAdamage
after treatment with CM-G.
Eight men (40%) showed alcohol dependence. Etha-
nolitselfdoesnotinducelesionsintheDNAofhumanlym-
phocytes, but its primary metabolite, acetaldehyde, evokes
breaks in single- and double-stranded DNA (Singh et al.,
1995). This, together with other factors that generate DNA
damage, may have contributed to some of the highest rates
of damaged DNA observed in these patients 1, 5, 8 and 10
before CM-G.
Six patients (30%) underwent radiotherapeutic treat-
ment prior to starting ADT (Table 1) in order to control lo-
calized prostate tumors. The exposure of patients with
cancer to therapeutic doses of radiation typically causes
free-radical induced changes in the genomic DNA of lym-
phocytes, (Olinski et al., 1996). Morever, the generation of
free radicals in the tissues may continue after exposure for
severalmonths(RobbinsandZhao,2004).Thehighradical
scavenging activity of CM-G from S. cerevisiae, with DS
0.8, was confirmed by paramagnetic resonance spectros-
copy (Kogan et al., 2005). Therefore, CM-G could be of
help in decreasing the oxidative damage caused by radio-
therapy.
Of the total number of patients, 85% had been occu-
pationally exposed for at least 10 years previously, to a
mixture of agrochemicals (Table 1), such as organophos-
phates, carbamates and organochlorines. This includes
DDTandBHC,bothbannedinBrazilforover20years,due
to high toxicity.
We believe that treatment with CM-G can be an effi-
cientprotectionagainstDNAdamagecausedbymutagenic
compounds through dismutagenic activity, either by its ca-
pability of blocking the action of damage-inducing agents,
or by bio-antimutagenic activity, which exerts its effect by
preventing damage or promoting DNA repair, since Oli-
veira et al. (2007) showed that this is a characteristic of
(1  3)(1  6)--D-glucan from S. cerevisiae.
Prostate carcinogenesis may be related to chronic and
acute prostate inflammation (De Marzo et al., 2007).The
possible chemoprotective effect of antioxidants may be a
formofprotectingprostatecellsfromtheDNAdamagethat
normally occurs in the setting of inflammatory lesions
(Smigel, 1998). Thus, there is a possibility that the DNA
damage generated by the typical inflammation process was
reduced through the administration of CM-G.
The results presented here highlight the protective ef-
fect of CM-G against DNA damage, which was shown for
thefirsttimeinhumans.TheseresultssuggestthatCM-Gis
potentially useful for improving the short-term survival of
patients with advanced PCa. Studies are underway on the
further beneficial effects of CM-G administration, such as
those related to immunomodulation, to assess the possibil-
ity of CM-G use improving prognosis in these patients.
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Figure 1 - Distribution of damaged cells into different classes of DNA
damage, observed through comet assay, for patients with advanced pros-
tate cancer before and after 28 days-treatment with carboxymethyl-glucan
(CM-G); B = before and A = after. Bars denote minimum and maximum
values observed in each damage-class, and the horizontal line inside the
box representing the median; *denotes p  0.05, a statistically significant
difference from the result before the treatment, as determined by the
Mann-Whitney test.
Figure 2 - DNA damage scores observed by comet assay in patients with
advanced cancer prostate before and after 28 days-treatment with car-
boxymethyl-glucan (CM-G); B = before and A = after. Bars denote the
minimum and maximum values observed for each score, the horizontal
line inside the box representing the median. *denotes p  0.05, a statisti-
cally significant difference between the results before and after treatment,
as determined by the Mann-Whitney test.References
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